The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

C. Kent Osborne

Breast Center at Baylor College of Medicine

1 Baylor Plaza

MS 600

Houston

USA

[email]@breastcenter.tmc.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Breast Center at Baylor College of Medicine, 1 Baylor Plaza, MS 600, Houston, USA. 2002 - 2005
  • Breast Center, Baylor College of Medicine and The Methodist Hospital, Houston, Texas 77030-3798, USA. 2005
  • Baylor College of Medicine, Breast Center, Houston, Texas 77030, USA. 2001 - 2003

References

  1. Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. Osborne, C.K., Shou, J., Massarweh, S., Schiff, R. Clin. Cancer Res. (2005) [Pubmed]
  2. Estrogen-receptor biology: continuing progress and therapeutic implications. Osborne, C.K., Schiff, R. J. Clin. Oncol. (2005) [Pubmed]
  3. Aromatase inhibitors: future directions. Osborne, C.K., Schiff, R. J. Steroid Biochem. Mol. Biol. (2005) [Pubmed]
  4. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. Osborne, C.K., Bardou, V., Hopp, T.A., Chamness, G.C., Hilsenbeck, S.G., Fuqua, S.A., Wong, J., Allred, D.C., Clark, G.M., Schiff, R. J. Natl. Cancer Inst. (2003) [Pubmed]
  5. Role of molecular and genetic markers in breast cancer treatment decisions. Osborne, C.K., Arteaga, C.L. J. Clin. Oncol. (2003) [Pubmed]
  6. Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial. Osborne, C.K., Pippen, J., Jones, S.E., Parker, L.M., Ellis, M., Come, S., Gertler, S.Z., May, J.T., Burton, G., Dimery, I., Webster, A., Morris, C., Elledge, R., Buzdar, A. J. Clin. Oncol. (2002) [Pubmed]
  7. Estrogen receptor: current understanding of its activation and modulation. Osborne, C.K., Schiff, R., Fuqua, S.A., Shou, J. Clin. Cancer Res. (2001) [Pubmed]
 
WikiGenes - Universities